BridgeMD
Tests treatment safety and results for Cervical Cancer Screening
Official title Optimization of Cervical Cancer Screening Strategies Among Women Living With HIV: Effectiveness and Implementation of Decentralized Approach Using a Mobile Team With HPV Testing in the Western Region of Cameroon
ClinicalTrials.gov ID: NCT07181278
What this study is testing
- What it's testing
- Context. Cervical cancer (CC) is a leading cause of death among women living with HIV (WLHIV) in resource-limited settings.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 to 49, women only
You may be able to join if
- Women
- HIV infection
- Age between 25 and 49 years old
- Receiving or starting ARV treatment
- Agreeing to participate in the study and having signed the consent
You likely can't join if
- Current pregnancy
- Hysterectomy
- Treatment of cervical lesions within 12 months
- Expected follow-up difficulties: planned absence that could interfere with the participation in the study (e.g., travel abroad, relocation, imminent...
- Any pathology or concomitant treatment which, in the opinion of the investigators, contraindicates participation or prevents satisfactory...
- menstrual bleeding
See the full eligibility criteria
- Women
- HIV infection
- Age between 25 and 49 years old
- Receiving or starting ARV treatment
- Agreeing to participate in the study and having signed the consent
- Current pregnancy
- Hysterectomy
- Treatment of cervical lesions within 12 months
- Expected follow-up difficulties: planned absence that could interfere with the participation in the study (e.g., travel abroad, relocation, imminent transfer, etc.);
- Any pathology or concomitant treatment which, in the opinion of the investigators, contraindicates participation or prevents satisfactory participation in the study Deferred inclusion if
- menstrual bleeding
- Postpartum (\<12 weeks after delivery)
- Clinical signs of cervical or pelvic infection
The study team makes the final eligibility decision.
Where it's taking place
- Bafoussam, Cameroon
- Bandjoun, Cameroon
- Foumbot, Cameroon
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 25 years to 49 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bafoussam, Cameroon; Bandjoun, Cameroon; Foumbot, Cameroon. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.